A selective HDAC8 inhibitor potentiates antitumor immunity and efficacy of immune checkpoint blockade in hepatocellular carcinoma [ChIP-seq]

Accession: GSE164443
Source / host: GEO — NCBI GEO FTP
Disease relevance: MASLD / NAFLD / NASH (category: Epigenetic, subtype: chromatin accessibility/ChIP)
Modality / assay: ATAC/ChIP
Platform: Genome binding/occupancy profiling by high throughput sequencing, GPL20301
Organism: human
Samples: 20
Size (indexed): 21.4 GB (22930498603 bytes)
Downloaded bytes: 21.4 GB (22930498603 bytes)
Access / raw: public / OPEN-raw

Download

Files

FileSizeSHA256
GSE164443_RAW.tar21.4 GB15074e840012b32f…
filelist.txt5.0 KBb3a28c5f6389961e…

Index note: 2 suppl file(s); GSE164443_RAW.tar

Crawled by masld-atlas-crawler v1.0 at 2026-08-02T21:58:53Z.

About this dataset

This Genome binding/occupancy profiling by high throughput sequencing, GPL20301 dataset provides single-cell gene expression from human liver samples, with disease state recorded as MASLD/NAFLD/NASH. It profiles about 20 cells or nuclei.

Analyze it in Drylab

Open this dataset in Drylab and ask a question in plain language. The AI agent loads the files, runs the analysis in a ready sandbox and explains each result. A typical first pass:

  1. Load the filtered feature-barcode matrix (HDF5) and run quality control on counts, genes and mitochondrial reads per cell.
  2. Normalize, select variable genes, then cluster the cells and draw a UMAP.
  3. Annotate clusters with marker genes and compare the cell-type mix between conditions.
  4. Run differential expression between cell types or samples to characterize masld/nafld/nash biology.